WO2005005668A3 - Diagnosis and treatment methods related to aging (8a) - Google Patents
Diagnosis and treatment methods related to aging (8a) Download PDFInfo
- Publication number
- WO2005005668A3 WO2005005668A3 PCT/US2004/021944 US2004021944W WO2005005668A3 WO 2005005668 A3 WO2005005668 A3 WO 2005005668A3 US 2004021944 W US2004021944 W US 2004021944W WO 2005005668 A3 WO2005005668 A3 WO 2005005668A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aging
- biological aging
- normal
- diagnosis
- treatment methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04777802A EP1649063A2 (en) | 2003-07-08 | 2004-07-08 | Diagnosis and treatment methods related to aging (8a) |
CA002531420A CA2531420A1 (en) | 2003-07-08 | 2004-07-08 | Diagnosis and treatment methods related to aging (8a) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48522203P | 2003-07-08 | 2003-07-08 | |
US60/485,222 | 2003-07-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005005668A2 WO2005005668A2 (en) | 2005-01-20 |
WO2005005668A3 true WO2005005668A3 (en) | 2005-09-09 |
Family
ID=34062070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/021944 WO2005005668A2 (en) | 2003-07-08 | 2004-07-08 | Diagnosis and treatment methods related to aging (8a) |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1649063A2 (en) |
CA (1) | CA2531420A1 (en) |
WO (1) | WO2005005668A2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025194A (en) * | 1997-11-19 | 2000-02-15 | Geron Corporation | Nucleic acid sequence of senescence asssociated gene |
WO2003000861A2 (en) * | 2001-06-22 | 2003-01-03 | The Regents Of The University Of California | Eukaryotic genes involved in adult lifespan regulation |
-
2004
- 2004-07-08 CA CA002531420A patent/CA2531420A1/en not_active Abandoned
- 2004-07-08 WO PCT/US2004/021944 patent/WO2005005668A2/en active Application Filing
- 2004-07-08 EP EP04777802A patent/EP1649063A2/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025194A (en) * | 1997-11-19 | 2000-02-15 | Geron Corporation | Nucleic acid sequence of senescence asssociated gene |
WO2003000861A2 (en) * | 2001-06-22 | 2003-01-03 | The Regents Of The University Of California | Eukaryotic genes involved in adult lifespan regulation |
Non-Patent Citations (5)
Title |
---|
LIO D ET AL: "Gender-specific association between -1082 IL-10 promoter polymorphism and longevity", GENES AND IMMUNITY, vol. 3, no. 1, February 2002 (2002-02-01), pages 30 - 33, XP008039832, ISSN: 1466-4879 * |
MERCHED A ET AL: "APOLIPOPROTEIN AIV CODON 360 MUTATION INCREASES WITH HUMAN AGING AND IS NOT ASSOCIATED WITH ALZHEIMER'S DISEASE", NEUROSCIENCE LETTERS, LIMERICK, IE, vol. 242, no. 2, 13 February 1998 (1998-02-13), pages 117 - 119, XP000863724, ISSN: 0304-3940 * |
MICHIKAWA Y ET AL: "Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 286, 22 October 1999 (1999-10-22), pages 774 - 779, XP002179334, ISSN: 0036-8075 * |
MOCCHEGIANI EUGENIO ET AL: "MTmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: Lessons from very old mice and humans", EXPERIMENTAL GERONTOLOGY, vol. 37, no. 2-3, January 2002 (2002-01-01), pages 349 - 357, XP002312292, ISSN: 0531-5565 * |
ZHOU YIHUA ET AL: "A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 94, no. 24, 25 November 1997 (1997-11-25), pages 13215 - 13220, XP002312293, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
CA2531420A1 (en) | 2005-01-20 |
EP1649063A2 (en) | 2006-04-26 |
WO2005005668A2 (en) | 2005-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003099771A3 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
WO2006092668A3 (en) | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same | |
WO2005000895A3 (en) | Vegf traps and therapeutic uses thereof | |
WO2008080134A3 (en) | 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors | |
DE602004014117D1 (en) | THIAZOLE FOR USE AS INHIBITORS OF PROTEIN KINASES | |
AU2005253776A8 (en) | Screening methods using c-Abl, Fyn and Syk in combination with tau protein | |
WO2007030680A3 (en) | Triazole derivatives useful as axl inhibitors | |
WO2004076639A8 (en) | Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus | |
WO2004071447A3 (en) | Substituted azole derivatives as therapeutic agents | |
WO2004071448A3 (en) | Substituted azole derivatives as inhibitors of protein tyrosine phosphatases | |
AU2002305450A1 (en) | Proteomimetic compounds and methods | |
WO2006059234A3 (en) | Bicyclic amides as kinase inhibitors | |
WO2001001748A3 (en) | Peptide compounds that bind her2 | |
WO1999040197A3 (en) | Variants of the angiogenic factor vascular endothelial cell growth factor: vegf | |
WO2005002526A3 (en) | Method and compositions for treatment of viral infections | |
WO2005000335A3 (en) | Use of genes differentially expressed during aging of liver for treatment and diagnosis | |
WO2004009024A3 (en) | Modulation of protein kinase c-iota expression | |
WO2004094476A3 (en) | Compositions and methods relating to stop-1 | |
WO2005110460A3 (en) | Diagnosis and treatment methods related to aging, especially in muscle (14.1) | |
WO2001040313A3 (en) | Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof | |
WO2010065536A3 (en) | Recombinant bone marrow stromal antigen-2 in the treatment of autoimmune diseases | |
WO2005005668A3 (en) | Diagnosis and treatment methods related to aging (8a) | |
WO2002020003A3 (en) | Use of carp inhibitors for the treatment of heart diseases | |
WO2004089982A3 (en) | April variants and methods thereof | |
WO2004013311A3 (en) | Compositions and methods relating to ovarian specific genes and proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2531420 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004777802 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004777802 Country of ref document: EP |